H 型高血压在慢性肾脏病中的研究进展

doi:10.3969/j.issn.1671-4091.2020.11.012

摘要/Abstract

摘要： 【摘要】慢性肾脏病的治疗面临巨大的困难和挑战，当前的治疗主要以干预危险因素为主。H 型高血压与慢性肾脏病患者肾功能的减退及心血管病并发症的发生有关。现就H 型高血压的定义、流行病学、与慢性肾脏病的关系以及导致其进展的机制进行综述，以提高临床医师对H 型高血压与慢性肾脏病关系的认识，协助临床治疗。

关键词: 慢性肾脏病, 高同型半胱氨酸血症, H 型高血压, 协同作用, 氧化应激, 炎症反应

Abstract: 【Abstract】Great difficulties and challenges are encountered in the treatment of chronic kidney disease, and the current treatment is mainly focused on the intervention of the risk factors. H-type hypertension is associated with renal insufficiency and cardiovascular complications in chronic kidney disease patients. This article reviews the definition, epidemiology, relationship between H-type hypertension and chronic kidney disease, and the mechanism that H-type hypertension leads to the progression of chronic kidney disease, in order to improve our understanding about the relationship between H-type hypertension and chronic kidney disease, which may be useful for clinical treatment of hypertension in chronic kidney disease patients.

Key words: Chronic kidney disease, Hyperhomocysteinemia, H-type hypertension, Synergistic effect, Oxidative stress, Inflammation

中图分类号:

R692.5

赵亚, 王俭勤. H 型高血压在慢性肾脏病中的研究进展[J]. 中国血液净化, 2020, 19(11): 768-771.

参考文献

[1]Mills KT, Xu Y, Zhang W, et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010[J].Kidney Int, 2015, 88(5):950-957 [2]Webster AC, Nagler EV, Morton RL, et al.Chronic Kidney Disease[J].Lancet, 2017, 389(10075):1238-1252 [3]Zhang L, Wang F, Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet, 2012, 379(9818):815-822 [4]Hill NR, Fatoba ST, Oke JL, et al.Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis[J].PLoS One, 2016, 11(7):e0158765- [5]Small HY, Migliarino S, Czesnikiewicz-Guzik M, et al.Hypertension: Focus on autoimmunity and oxidative stress.[J].Free Radic Biol Med, 2018, 125:104-115 [6]Ji A, Pan C, Wang H, et al.Prevalence and Associated Risk Factors of Chronic Kidney Disease in an Elderly Population from Eastern China. [J].Int J Environ Res Public Health, 2019, 16(22):4383- [7]胡大一, 徐希平.有效控制“H型”高血压——预防卒中的新思路. [J].中华内科杂志, 2008, (12):976-977 [8]Veeranki S, Gandhapudi SK, Tyagi SC.Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension[J].Can J Physiol Pharmacol, 2017, 95(3):239-246 [9]班倩芸.华东地区农村高血压人群高同型半胱氨酸血症的患病情况及其影响因素 [硕士].[J].安徽医科大学, 2018, :- [10]Ma L, Li L, Tang Z.Epidemiological characteristics of hyperhomocysteinemia and H-type hypertension in the elderly in Beijing,China[J].Clin Exp Hypertens, 2017, 39(7):640-644 [11]Ye Z, Wang C, Zhang Q, et al.Prevalence of Homocysteine-Related Hypertension in Patients With Chronic Kidney Disease[J].J Clin Hypertens (Greenwich), 2017, 19(2):151-160 [12]Chao MC, Hu SL, Hsu HS, et al.Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population[J].J Nephrol, 2014, 27(3):299-305 [13]Ye Z, Zhang Q, Li Y, et al.High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease. [J].Nutrients, 2016, 8(10):- [14]Kong X, Ma X, Zhang C, et al.Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort[J].Int Urol Nephrol, 2017, 49(4):661-667 [15]Levi A, Cohen E, Levi M, et al.Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study[J].Eur J Intern Med, 2014, 25(10):951-955 [16]Xie D, Yuan Y, Guo J, et al.Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults.[J].Sci Rep, 2015, 5:16268- [17]Shi W, Zhou Y, Wang H, et al.Synergistic interaction of hypertension and hyperhomocysteinemia on chronic kidney disease: Findings from the National Health and Nutrition Examination Survey 1999-2006[J].J Clin Hypertens (Greenwich), 2019, 21(10):1567-1577 [18]Panieri E, Santoro MM.ROS signaling and redox biology in endothelial cells[J].Cell Mol Life Sci, 2015, 72(17):3281-3303 [19]Zhou L, Chen X, Lu M, et al.Wntβ-catenin links oxidative stress to podocyte injury and proteinuria[J].Kidney Int, 2019, 95(4):830-845 [20]Li L, Lai EY, Luo Z, et al.Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease[J].Kidney Int, 2017, 92(3):625-633 [21]Yokoro M, Nakayama Y, Yamagishi SI, et al.Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia[J].J Am Soc Nephrol, 2017, 28(9):2670-2680 [22]Manickam N, Patel M, Griendling KK, et al.RhoARho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2Nox4-derived reactive oxygen species[J].Am J Physiol Renal Physiol, 2014, 307(2):F159-171 [23]Jha JC, Banal C, Okabe J, et al.NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy[J].Diabetes, 2017, 66(10):2691-2703 [24]Zhang S, Tan X, Chen Y, et al.Postconditioning protects renal fibrosis by attenuating oxidative stress-induced mitochondrial injury[J].Nephrol Dial Transplant, 2017, 32(10):1628-1636 [25]Pavlakou P, Liakopoulos V, Eleftheriadis T, et al.Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms-Biomarkers-Interventions, and Future Perspectives. [J].Oxid Med Cell Longev, 2017, 2017:6193694- [26]金珍杰, 何平.氧化应激在肾脏疾病发生发展中作用的研究进展[J].山东医药, 2020, 60(14):103-105 [27]Wen YD, Wang H, Kho SH, et al.Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress[J].PLoS One, 2013, 8(2):e53147- [28]Bos EM, Wang R, Snijder PM, et al.Cystathionine γ-lyase protects against renal ischemiareperfusion by modulating oxidative stress[J].J Am Soc Nephrol, 2013, 24(5):759-770 [29]Ostrakhovitch EA, Tabibzadeh S.Homocysteine in Chronic Kidney Disease. [J].Adv Clin Chem, 2015, 72:77-106 [30]Chen DD, Chen LY, Xie JB, et al.Tetrahydrobiopterin regulation of eNOS redox function[J].Curr Pharm Des, 2014, 20(22):3554-3562 [31]Bai J, Zhang N, Hua Y, et al.Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts[J].PLoS One, 2013, 8(9):e72120- [32]Mordi I, Mordi N, Delles C, et al.Endothelial dysfunction in human essential hypertension[J].J Hypertens, 2016, 34(8):1464-1472 [33]Li W, Xiong L, Fan L, et al.Association of baseline,longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients[J].BMC Nephrol, 2017, 18(1):211- [34]Neirynck N, Glorieux G, Schepers E, et al.Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study[J].PLoS One, 2015, 10(3):e0122073- [35]Mihai S, Codrici E, Popescu ID, et al.Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. [J].J Immunol Res, 2018, 2018:2180373- [36]Foresto-Neto O, ávila VF, Arias SCA, et al.NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model[J].Lab Invest, 2018, 98(6):773-782 [37]Zhang Q, Conley SM, Li G, et al.Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation[J].Kidney Blood Press Res, 2019, 44(4):513-532 [38]Lv W, Booz GW, Wang Y, et al.Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. , 2018, 820:65-76.[J].Eur J Pharmacol, 2018, 820:65-76 [39]Cafiero C, Gigante M, Brunetti G, et al.Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems[J].Nephrol Dial Transplant, 2018, 33(1):65-75 [40]Gluba-Brzózka A, Franczyk B, Olszewski R, et al.The Influence of Inflammation on Anemia in CKD Patients.[J].Int J Mol Sci, 2020, 21(3):- [41]de Oliveira Júnior WV, Sabino Ade P, Figueiredo RC, et al.Inflammation and poor response to treatment with erythropoietin in chronic kidney disease[J].J Bras Nefrol, 2015, 37(2):255-263 [42]Meng S, Ciment S, Jan M, et al.Homocysteine induces inflammatory transcriptional signaling in monocytes. Front Biosci (Landmark Ed), 2013, 18:685-695.[J].Front Biosci (Landmark Ed), 2013, 18:685-695 [43]Wang R, Wang Y, Mu N, et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J].Lab Invest, 2017, 97(8):922-934 [44]Abais JM, Zhang C, Xia M, et al.NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia[J].Antioxid Redox Signal, 2013, 18(13):1537-1548